<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger's disease</z:e> (BD) is a condition characterized by prominent brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> with <z:hpo ids='HP_0002119'>ventricular dilatation</z:hpo>, diffuse white matter (WM) lesions and a scattering of lacunar <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>BD patients have <z:hpo ids='HP_0000726'>dementia</z:hpo>, and have vascular risk factors, focal cerebrovascular deficits and evidence of subcortical <z:e sem="disease" ids="C0262405" disease_type="Disease or Syndrome" abbrv="">cerebral dysfunction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>From our clinical studies, the most effective prophylaxis against the development of BD is to manage the <z:hpo ids='HP_0000822'>hypertension</z:hpo>, especially a high nocturnal blood pressure, in the early stage patients showing only a scattering of lacunes and/or mild WM lesions </plain></SENT>
<SENT sid="3" pm="."><plain>The pathogenesis of BD is likely to be <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> due to hypertensive small artery disease with capillary <z:e sem="disease" ids="C0235910" disease_type="Disease or Syndrome" abbrv="">collagenosis</z:e>, which causes the multiple lacunes and the alterations in the glia and axons </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> and a subsequent dysfunction of the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) may cause the WM lesions </plain></SENT>
<SENT sid="5" pm="."><plain>A compromised <z:chebi fb="2" ids="33602">BBB</z:chebi> will permit the entry of serum components, immunoglobulins, complements and fibrinogen into the perivascular neural parenchyma </plain></SENT>
<SENT sid="6" pm="."><plain>These substances may subsequently activate both astro- and microglia and thus damage the myelin structures </plain></SENT>
<SENT sid="7" pm="."><plain>Experimentally, <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi>, <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> and FK 506 suppressed both the glial activation and WM changes after <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The pro-thrombotic state of the microcirculation in BD patients may also contribute to local <z:mp ids='MP_0001845'>inflammation</z:mp> and the <z:chebi fb="2" ids="33602">BBB</z:chebi> dysfunction, because thrombin and <z:chebi fb="0" ids="26347">prostanoids</z:chebi> are involved in various tissue reactions including <z:hpo ids='HP_0002181'>brain edema</z:hpo> and glial activation </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, novel therapeutic approaches using the administration of anti-thrombin and cyclo-oxygenase-2 inhibitors as well as <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> may be useful for preventing the progression of BD </plain></SENT>
</text></document>